Key result
All surveyed HbA1c assays achieve DCCT alignment, but variant haemoglobins compromise guideline accuracy.
Answers are grounded in this paper and cite their sources.
Survey of manufacturers reveals variant haemoglobins alter HbA1c testing accuracy, indicating that certain analytical methods may be unreliable for clinical guidelines.
AIMS: To review 'Diabetes Control and Complications Trial (DCCT)-aligned' HbA(1c) reporting in UK, use of individual/network equations relating IFCC calibration to 'DCCT alignment', and whether HbA(1c) in the presence of variant haemoglobins is, according to manufacturers, suitable for current, clinical guidelines. METHODS: Questionnaire sent to nine manufacturers and responses analysed. RESULTS: All methods were certified as 'DCCT-aligned' by National Glycohemoglobin Standardization Program (NGSP); UK EQA schemes reported 95% of results 'DCCT-aligned' in December 2004. The master equation relating networks was used by six manufacturers and specific equations for individual methods by three. HbA(1c) results from laboratory/point of care testing analysers can be affected by variant haemoglobins including elevated HbF; only IE HPLC (and LPLC) detect their presence. If chromatographic separation is ideal in heterozygous patients, laboratories either choose not to report HbA(1c) and propose another strategy for monitoring glycaemia, or report HbA(1c) and issue a caution that it may not be appropriate for guidelines. HbA(1c) reported from immunochemistry or affinity chromatography in presence of variant haemoglobins, may not be reliable for use with clinical guidelines. CONCLUSIONS: For clinical care, HbA(1c) must reflect its relationship to glycaemia in clinical trials underpinning national guidelines. A flowchart to establish if HbA(1c) measurement is appropriate has been produced for use in a clinical setting.
No takes yet. Share an insight, caveat, or question.
Manley et al. (2006) studied Diabetes mellitus / Variant haemoglobins (n=9). HbA1c measurement methods and calibration was evaluated on Certification as DCCT-aligned and suitability of HbA1c measurement in the presence of variant haemoglobins. HbA1c methods from all 9 surveyed manufacturers were NGSP DCCT-aligned, though variant haemoglobins can make results unreliable for clinical guidelines.
Synapse has enriched 10 related papers. Consider them for comparative context: